SCHEMBL14385449

SCHEMBL14385449

CC1OC(=O)C(=O)OC1C

nearest known ligand 0.40

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 1/20 0.40
PPARG P37231 6/20 0.37
CA1 P00915 1/20 0.35
CA9 Q16790 1/20 0.35
MAOA P21397 1/20 0.30
PARP1 P09874 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23097435 1.00 SMN1; SMN2 (0.40) SMN1; SMN2PPARGCA1CA9MAOA
SCHEMBL21531887 0.78 SMN1; SMN2 (0.32) SMN1; SMN2PPARG
SCHEMBL10831352 0.78 MAOA (0.33) SMN1; SMN2PPARGMAOAPARP1
SCHEMBL13594666 0.77
SCHEMBL5014585 0.77
SCHEMBL19125529 0.77
SCHEMBL137875 0.77
SCHEMBL432317 0.77
SCHEMBL431549 0.77
SCHEMBL11298975 0.77

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119930998-A Catalytic-free full-end-group hydroxyl hyperbranched polyoxalate and preparation method and application thereof 宁波宝亭生物科技有限公司 2025-05-06 CN claimed
US-11742519-B2 Silicon-based energy storage devices with electrolyte additive compounds ENEVATE CORPORATION (US) 2023-08-29 US claimed
US-20200388880-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE ADDITIVE COMPOUNDS ENEVATE CORPORATION 2020-12-10 US claimed
CN-119930998-A Catalytic-free full-end-group hydroxyl hyperbranched polyoxalate and preparation method and application thereof 宁波宝亭生物科技有限公司 2025-05-06 CN disclosed
WO-2024145741-A1 ELECTROLYTE, BATTERY, AND ELECTRICAL DEVICE 宁德时代新能源科技股份有限公司 2024-07-11 WO disclosed
US-20230307710-A1 NONAQUEOUS ELECTROLYTE AND NONAQUEOUS ELECTROLYTE SECONDARY BATTERY INCLUDING THE SAME Prime Planet Energy & Solutions, Inc. (JP) 2023-09-28 US disclosed
US-11742519-B2 Silicon-based energy storage devices with electrolyte additive compounds ENEVATE CORPORATION (US) 2023-08-29 US disclosed
US-11742519-B2 Silicon-based energy storage devices with electrolyte additive compounds ENEVATE CORPORATION (US) 2023-08-29 US disclosed
US-11742519-B2 Silicon-based energy storage devices with electrolyte additive compounds ENEVATE CORPORATION (US) 2023-08-29 US disclosed
US-11581579-B2 Lithium ion secondary battery CONTEMPORARY AMPEREX TECHNOLOGY CO., LIMITED (CN) 2023-02-14 US disclosed
US-11008352-B2 Method for producing cyclometalated iridium complex NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2021-05-18 US disclosed
US-20200388880-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE ADDITIVE COMPOUNDS ENEVATE CORPORATION 2020-12-10 US disclosed
US-20200388880-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE ADDITIVE COMPOUNDS ENEVATE CORPORATION 2020-12-10 US disclosed
US-20200181181-A1 METHOD FOR PRODUCING CYCLOMETALATED IRIDIUM COMPLEX NATIONAL INSTITUTE OF ADVANCED INDUSTRIAL SCIENCE AND TECHNOLOGY (JP) 2020-06-11 US disclosed
US-20200106134-A1 ELECTROLYTE SOLUTION FOR LITHIUM ION SECONDARY BATTERY AND LITHIUM ION SECONDARY BATTERY USING SAME NEC CORPORATION (JP) 2020-04-02 US disclosed
US-10361464-B2 Electrolytic solution and secondary battery NEC CORPORATION (JP) 2019-07-23 US disclosed
US-20170149097-A1 ELECTROLYTIC SOLUTION AND SECONDARY BATTERY NEC CORPORATION (JP) 2017-05-25 US disclosed
US-20170149097-A1 ELECTROLYTIC SOLUTION AND SECONDARY BATTERY NEC CORPORATION (JP) 2017-05-25 US disclosed
WO-2007124856-A1 OXALIC ACID-CONTAINING LIGHTENING AND/OR DYEING AGENTS HENKEL AG & CO. KGAA (DE) 2007-11-08 WO disclosed
WO-2007029156-A2 ISOINDOLEDIONE DERIVATIVES AS ADRENERGIC RECEPTOR ANTAGONISTS RANBAXY LABORATORIES LIMITED (IN) 2007-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200388880-A1 SILICON-BASED ENERGY STORAGE DEVICES WITH ELECTROLYTE ADDITIVE COMPOUNDS SOST, CA1, DUOX2 SMN1; SMN2 1763/4885PPARG 3467/4885CA1 2/4885
US-11742519-B2 Silicon-based energy storage devices with electrolyte additive compounds SOST, CA1, DUOX2 SMN1; SMN2 1763/4885PPARG 3467/4885CA1 2/4885
US-20200181181-A1 METHOD FOR PRODUCING CYCLOMETALATED IRIDIUM COMPLEX CBR3, NOX5, CBR1 SMN1; SMN2 4735/4885PPARG 3439/4885CA1 1529/4885
US-11008352-B2 Method for producing cyclometalated iridium complex CBR3, NOX5, CBR1 SMN1; SMN2 4735/4885PPARG 3439/4885CA1 1529/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.